Clinical Tools
VACCINE REMINDER
| IS LANSOPRAZOLE SAFE IN CHILDREN FOR TREATMENT OF GER? | |
|
J Pediatr Gastroenterol Nutr 2002; 35 Suppl 4
In a phase I/II, open-label, multicenteric (11 sites) study, 66 children with GERD and erosive esophagitis were treated with lansoprazole -15 mg for children < 30 kg (0.6-1.2mg/kg/day) and 30 mg for children > 30 kg (0.7-0.9mg/kg/day) once daily for 8 to 12 weeks. In patients who were symptomatic even 2 weeks after treatment, the dose of lansoprasole was increased to 60mg daily. All the children responded symptomatically to the above therapy. Commonest side effects seen were constipation in 3 children and headache in 2 children. Mean fasting serum gastrin levels were significantly increased from 58.0 pg/mL at baseline to 112.4 pg/mL at week 2 and 121.9 pg/mL at the final visit. Thus, though this study concluded that lansoprazole is safe in children, its effect on gastrin level seems to be investigated further. Also this study group seems to be too small, and to determine its efficacy in children, a longer study with more number of patients should be evaluated. Last updated on 25 - 03 - 2003 |
Pediatric Oncall Journal
Search
Ped Tools
Partner Sites
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
copyright ©2011 website design & development by Levioza






